132 related articles for article (PubMed ID: 24702231)
21. Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J
Anticancer Res; 2000; 20(5C):3975-81. PubMed ID: 11268487
[TBL] [Abstract][Full Text] [Related]
22. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma.
Tang Q; Liu YF; Zhu XJ; Li YH; Zhu J; Zhang JP; Feng ZQ; Guan XH
Hum Pathol; 2009 Mar; 40(3):300-5. PubMed ID: 18992912
[TBL] [Abstract][Full Text] [Related]
23. Increased alpha-B-crystallin expression in mammary metaplastic carcinomas.
Chan SK; Lui PC; Tan PH; Yamaguchi R; Moriya T; Yu AM; Shao MM; Hliang T; Wong SI; Tse GM
Histopathology; 2011 Aug; 59(2):247-55. PubMed ID: 21884203
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
25. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.
Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot A; van Tienoven DT; Beex LV; Sweep FC
Cancer; 2004 Aug; 101(3):486-94. PubMed ID: 15274061
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
Khan AJ; King BL; Smith BD; Smith GL; DiGiovanna MP; Carter D; Haffty BG
Clin Cancer Res; 2002 Feb; 8(2):540-8. PubMed ID: 11839675
[TBL] [Abstract][Full Text] [Related]
27. Plasminogen activator system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx.
Salerno G; Di Vizio D; Staibano S; Mottola G; Quaremba G; Mascolo M; Galli V; De Rosa G; Insabato L
BMC Cancer; 2006 Jun; 6():146. PubMed ID: 16740156
[TBL] [Abstract][Full Text] [Related]
29. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
[TBL] [Abstract][Full Text] [Related]
30. Grade as a prognostic factor in oral squamous cell carcinoma: a population-based analysis of the data.
Thomas B; Stedman M; Davies L
Laryngoscope; 2014 Mar; 124(3):688-94. PubMed ID: 23945976
[TBL] [Abstract][Full Text] [Related]
31. Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC).
Magnussen S; Rikardsen OG; Hadler-Olsen E; Uhlin-Hansen L; Steigen SE; Svineng G
PLoS One; 2014; 9(7):e101895. PubMed ID: 24999729
[TBL] [Abstract][Full Text] [Related]
32. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
[TBL] [Abstract][Full Text] [Related]
33. Plasminogen activator inhibitor type 1 is the most significant of the usual tissue prognostic factors in node-negative breast ductal adenocarcinoma independent of urokinase-type plasminogen activator.
Descotes F; Riche B; Saez S; De Laroche G; Datchary J; Roy P; André J; Bobin JY
Clin Breast Cancer; 2008 Apr; 8(2):168-77. PubMed ID: 18621614
[TBL] [Abstract][Full Text] [Related]
34. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
Muirhead DM; Hoffman HT; Robinson RA
J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
[TBL] [Abstract][Full Text] [Related]
35. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Rosenquist K
Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
[TBL] [Abstract][Full Text] [Related]
36. [Plasminogen activator inhibitor 1 and prognosis in breast carcinoma].
Mayerhofer K; Stolzlechner J; Yildiz S; Haider K; Heinzl H; Jakesz R; Pecherstorfer M; Rosen H; Sevelda P; Zeillinger R; Speiser P
Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):23-7. PubMed ID: 8852782
[TBL] [Abstract][Full Text] [Related]
37. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
38. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma.
Fujieda S; Sunaga H; Tsuzuki H; Tanaka N; Saito H
Clin Cancer Res; 1998 Jul; 4(7):1583-90. PubMed ID: 9676830
[TBL] [Abstract][Full Text] [Related]
39. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
[TBL] [Abstract][Full Text] [Related]
40. High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma.
Cho JY; Chung HC; Noh SH; Roh JK; Min JS; Kim BS
Cancer; 1997 Mar; 79(5):878-83. PubMed ID: 9041148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]